Sector consensus Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
After hours 19:12:40 | |||
| 218.70 USD | -0.32% |
|
225.79 | +3.24% |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| 07-13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 230.93 | +5.26% | 15 | ||||||
| 669.22 | +18.66% | 23 | ||||||
| 203.85 | +11.22% | 21 | ||||||
| 414.83 | +30.17% | 27 | ||||||
| 232 | +15.07% | 19 | ||||||
| 256,664.68 | +49.57% | 24 | ||||||
| 264.08 | +18.06% | 18 | ||||||
| 472.33 | -11.16% | 12 | ||||||
| 71.89 | +3.2% | 14 | ||||||
| 181.81 | +9.12% | 16 | ||||||
| 138.56 | +17.93% | 6 | ||||||
| 70 | -2.28% | 12 | ||||||
| 130.53 | -2.74% | 12 | ||||||
| 36.41 | -7.49% | 11 | ||||||
| 127.05 | +12.06% | 21 | ||||||
| 129.38 | -6.45% | 13 | ||||||
| 610.05 | +91.92% | 19 | ||||||
| 92.1 | +72.5% | 20 | ||||||
| 53.59 | +1.4% | 17 | ||||||
| 66.57 | +35.92% | 14 | ||||||
| Average | 13,042.99 | +18.10% | 17 | ||||||
| Weighted average by Cap. | 19,851.55 | +18.68% | 19 |
Select your edition
All financial news and data tailored to specific country editions
